Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 44686 AL 44700

Restoring brain barriers: an innovative approach for treating neurological disorders

Lemarchant S, Engelhardt B, Cicchetti F, Bix GJ, Janus A, Godfrin Y, Blasco H, Campbell M, de Rus Jacquet A.

Fluids Barriers CNS. 2025 Jul 10;22(1):72. doi: 10.1186/s12987-025-00688-z.

Current Development of iPSC-Based Modeling in Neurodegenerative Diseases

Guo X, Wang X, Wang J, Ma M, Ren Q.

Int J Mol Sci. 2025 Apr 16;26(8):3774. doi: 10.3390/ijms26083774.

On astrocyte-neuron interactions: Broad insights from the striatum

Khakh BS.

Neuron. 2025 Oct 1;113(19):3079-3107. doi: 10.1016/j.neuron.2025.08.009. Epub 2025 Sep 18.

Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases

Chen L, Shen Q, Liu Y, Zhang Y, Sun L, Ma X, Song N, Xie J.

Signal Transduct Target Ther. 2025 Feb 3;10(1):31. doi: 10.1038/s41392-024-02071-0.

Associations Between Diabetes Mellitus and Neurodegenerative Diseases

Szablewski L.

Int J Mol Sci. 2025 Jan 10;26(2):542. doi: 10.3390/ijms26020542.

Autophagy, aging, and age-related neurodegeneration

Palmer JE, Wilson N, Son SM, Obrocki P, Wrobel L, Rob M, Takla M, Korolchuk VI, Rubinsztein DC.

Neuron. 2025 Jan 8;113(1):29-48. doi: 10.1016/j.neuron.2024.09.015. Epub 2024 Oct 14.

MECP2 Disorders

Kaur S, Christodoulou J.

2001 Oct 3 [updated 2025 Dec 4]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Diffuse putaminal degeneration without iron deposition in multiple system atrophy

Ueno SI, Tsunemi T, Taniguchi D, Hattori N.

J Parkinsons Dis. 2025 Aug;15(5):1019-1023. doi: 10.1177/1877718X251355592. Epub 2025 Jul 6.

Mercury exposure leading to functional vitamin B12 deficiency and subacute combined degeneration: a case report and literature review

Semnic I, Rački V, Perković O, Vuletić V.

Front Toxicol. 2025 Sep 9;7:1580275. doi: 10.3389/ftox.2025.1580275. eCollection 2025.

A rare case of adult-onset vanishing white matter leukoencephalopathy with movement disorder, expressing homozygous EIF2B3 and PRKN pathogenic variants

Douden BKA, Abufara YMA, Aldrabeeh MFA, Tell NRM, Abudaya I.

BMC Neurol. 2025 Jan 4;25(1):7. doi: 10.1186/s12883-024-04018-y.

PPP2R5D-Related Neurodevelopmental Disorder

Mirzaa G, Foss K, Sudnawa K, Chung WK.

2019 Jan 24 [updated 2025 Jan 9]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Lipid nanoparticle (LNP) mediated mRNA delivery in neurodegenerative diseases

Moosavi SG, Rahiman N, Jaafari MR, Arabi L.

J Control Release. 2025 May 10;381:113641. doi: 10.1016/j.jconrel.2025.113641. Epub 2025 Mar 20.

A CGG Repeat Expansion in CSNK1E Associated with Progressive Myoclonic Epilepsy with Incomplete Penetrance

Akçimen F, Alvarez Jerez P, Guliyeva U, Lee J, Malik L, Baker B, Salayev K, Guliyeva S, Billingsley KJ, Houlden H, Singleton AB, Blauwendraat C, Bandres-Ciga S, Kaiyrzhanov R.

Mov Disord. 2025 Nov;40(11):2469-2475. doi: 10.1002/mds.30326. Epub 2025 Aug 1.

Phenotypic spectrum, etiology and outcomes of infection-related movement disorders: An observational cohort study

Garg D, Makharia A, Agarwal A, Mustafa F, Radhakrishnan DM, Rajan R, Srivastava AK.

Parkinsonism Relat Disord. 2026 Jan;142:108135. doi: 10.1016/j.parkreldis.2025.108135. Epub 2025 Nov 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias